It’s a hat trick for Pegasus!
October 16, 2014 |
Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014
Pegasus, the UK’s leading independent health communications consultancy, picked up the prestigious “Consultancy of the Year” award at Tuesday night’s PR Week Awards 2014.
Pegasus was also successful in the “Mid-Sized Consultancy of the Year” category (for agencies with UK turnover between £2m and £10m), and completed its hat trick winning the “Healthcare: Ethical & OTC Consumer” award for its work on Bayer Animal Health’s Slimewatch campaign.
This win marks Pegasus’s evolution from a traditional PR agency to an integrated comms consultancy that offers a multiservice approach to its clients, including social, digital and creative services.
With campaigns that span local, national and international markets and the creation of a network of global independent affiliate agencies across five continents, it’s no surprise that Pegasus represents a raft of well known companies and brands such as GSK, Pfizer, Bayer, Holland & Barrett, Bio-Oil and Danone to name a few. These awards are further confirmation that the consultancy continues to go from strength to strength, creating outstanding integrated campaigns that really bring healthcare into the mainstream. This is the third consultancy award win for the agency this year.
It has seen five years of double-digit growth, with last year’s fee income of £6m helping it climb ten places in this year’s PR Week Top 150 PR Consultancies report to number 38.
Fishburn CEO, Ali Gee said: “Pegasus has everything; it’s clear who they are, what they do and what makes them special.
Their purpose – inspiring health decisions – defines everything they do, and we were particularly impressed by the way they have reached beyond the healthcare sector.” 
Lisa Bradley, managing director at Pegasus, commented: “We’re absolutely delighted to have won, not just one, but three awards at the PR Week Awards this year. I’ve always looked at the winners of the “Consultancy of the Year” award with great admiration and am so proud that we are now that agency.”
ENDS
For more information please contact Maria Boiling or Amy Simmons at Pegasus on 01273 712000 or mboiling@thisispegasus.co.uk / asimmons@thisispegasus.co.uk
Notes to editors
Located in Brighton with a 75-strong team of communications experts, Pegasus specialises in helping the public and private sector communicate healthy messages through integrated communications programmes. Focusing on an overall mission to ‘Inspire Healthy Decisions’ and driven by a health first, sector second approach, Pegasus has a demonstrative track record of creating and implementing campaigns that inspire change.
The Pegasus approach to planning starts by investing time understanding the varied nature of decisions in every area of people’s day to day lives, from the general public through to the healthcare professionals that treat and the policy makers that shape the environment in which they work. The consultancy’s fully integrated approach blends unrivalled health contacts across the international, national, consumer, regional and specialist press, with in-house corporate, creative, social and digital services.
Pegasus’s clients currently include GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil, Danone, Homedics, Novo Nordisk and Pierre Fabre. For more information please visit www.thisispegasus.co.uk.
This content was provided by Inizio
Company Details
Latest Content from Inizio
12 Challenges Big Pharma Faces in China
Published in eyeforpharma 16 November by Rachel Howard
Using mobile “diary” research to capture patient-generated insights in COPD
Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients
Biosimilars in 2018: EU doctors’ perceptions of RA drug market
Published in pharmaphorum October 2015 by Laurent Chanroux
Webinar: Understanding the Patient Journey in China 2015
Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.
Understanding Patient Willingness to Pay
Published in eyeforpharma 12 October by Rachel Howard
Infographic: Spondyloarthritis
Overview of spondyloarthritis patient profiles and treatment pathways.
Webinar: Demand assessment – Reflecting real world choices
How study design which reflects doctors’ real world choices can optimise results.
Evaluating the potential of a pre-launch prodct in a real-life setting
Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.
Competition from within
Published in eyeforpharma July 29 by Rachel Howard
Infographic: RA Perceptions
HCPs predict the future of the biologics market